Stocks
GlaxoSmithKline (GSK) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 4.09% | 24.9% | 6.55% | 4.33% | 9.37% | 7.03% | ||
| Changes by years, y/y, % | -1pp | +21pp | -18pp | -2pp | +5pp | +12.4% | |||
GlaxoSmithKline. ROA, %
GlaxoSmithKline. ROA, changes, pp
GlaxoSmithKline (GSK) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | 4.02% | 4.22% | 6.65% | 9.37% | 7.03% | 7.03% | |
| Changes by years, y/y, % | -2pp | -1pp | +2pp | +5pp | +3pp | |||
| Changes by quarters, q/q, % | 0pp | +0pp | +2pp | +3pp | -2pp | |||
